Overview

A Study to Compare Omeprazole Administered as Zegerid® Powder and as Prilosec® Capsule in Healthy Participants (P08050)(CL2010-12)

Status:
Completed

Trial end date:
2011-01-01

Target enrollment:

Participant gender:

Summary

This study compares the bioequivalence of omeprazole administered as either Zegerid® powder for oral suspension 20 mg or as Prilosec 40 mg capsule to healthy participants.

Phase:

Phase 1

Details

Lead Sponsor:

Bayer

Treatments:

Omeprazole
Omeprazole, sodium bicarbonate drug combination